308 related articles for article (PubMed ID: 9016218)
1. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD
AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
[TBL] [Abstract][Full Text] [Related]
2. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
Kneist W; Schreckenberger M; Bartenstein P; Grünwald F; Oberholzer K; Junginger T
Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
[TBL] [Abstract][Full Text] [Related]
3. Role of positron emission tomography in staging esophageal cancer.
Luketich JD; Schauer PR; Meltzer CC; Landreneau RJ; Urso GK; Townsend DW; Ferson PF; Keenan RJ; Belani CP
Ann Thorac Surg; 1997 Sep; 64(3):765-9. PubMed ID: 9307471
[TBL] [Abstract][Full Text] [Related]
4. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
[TBL] [Abstract][Full Text] [Related]
5. Improvement in staging of esophageal cancer with the addition of positron emission tomography.
Block MI; Patterson GA; Sundaresan RS; Bailey MS; Flanagan FL; Dehdashti F; Siegel BA; Cooper JD
Ann Thorac Surg; 1997 Sep; 64(3):770-6; discussion 776-7. PubMed ID: 9307472
[TBL] [Abstract][Full Text] [Related]
6. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
Meltzer CC; Luketich JD; Friedman D; Charron M; Strollo D; Meehan M; Urso GK; Dachille MA; Townsend DW
Clin Nucl Med; 2000 Nov; 25(11):882-7. PubMed ID: 11079584
[TBL] [Abstract][Full Text] [Related]
7. Imaging features of primary and recurrent esophageal cancer at FDG PET.
Skehan SJ; Brown AL; Thompson M; Young JE; Coates G; Nahmias C
Radiographics; 2000; 20(3):713-23. PubMed ID: 10835124
[TBL] [Abstract][Full Text] [Related]
8. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
Keswani RN; Early DS; Edmundowicz SA; Meyers BF; Sharma A; Govindan R; Chen J; Kohlmeier C; Azar RR
Gastrointest Endosc; 2009 Jun; 69(7):1210-7. PubMed ID: 19012886
[TBL] [Abstract][Full Text] [Related]
9. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
[TBL] [Abstract][Full Text] [Related]
10. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
Swisher SG; Erasmus J; Maish M; Correa AM; Macapinlac H; Ajani JA; Cox JD; Komaki RR; Hong D; Lee HK; Putnam JB; Rice DC; Smythe WR; Thai L; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
Cancer; 2004 Oct; 101(8):1776-85. PubMed ID: 15386332
[TBL] [Abstract][Full Text] [Related]
11. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
[TBL] [Abstract][Full Text] [Related]
12. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
Pifarré-Montaner P; Fernández-León A; de Juan R; del Ama-Salvador ME; Galán M; Gámez-Cenzano C; Sans M
Rev Esp Med Nucl; 2009; 28(3):101-5. PubMed ID: 19558949
[TBL] [Abstract][Full Text] [Related]
13. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
14. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
[TBL] [Abstract][Full Text] [Related]
15. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
[TBL] [Abstract][Full Text] [Related]
16. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
[TBL] [Abstract][Full Text] [Related]
17. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
Yoon YC; Lee KS; Shim YM; Kim BT; Kim K; Kim TS
Radiology; 2003 Jun; 227(3):764-70. PubMed ID: 12773680
[TBL] [Abstract][Full Text] [Related]
18. Is FDG-PET indicated for superficial esophageal cancer?
Little SG; Rice TW; Bybel B; Mason DP; Murthy SC; Falk GW; Rybicki LA; Blackstone EH
Eur J Cardiothorac Surg; 2007 May; 31(5):791-6. PubMed ID: 17337344
[TBL] [Abstract][Full Text] [Related]
19. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
Choi JY; Lee KH; Shim YM; Lee KS; Kim JJ; Kim SE; Kim BT
J Nucl Med; 2000 May; 41(5):808-15. PubMed ID: 10809196
[TBL] [Abstract][Full Text] [Related]
20. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
Flamen P; Lerut A; Van Cutsem E; De Wever W; Peeters M; Stroobants S; Dupont P; Bormans G; Hiele M; De Leyn P; Van Raemdonck D; Coosemans W; Ectors N; Haustermans K; Mortelmans L
J Clin Oncol; 2000 Sep; 18(18):3202-10. PubMed ID: 10986052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]